EP1425383A4 - Stabilisierung von zellen und biologischen präparaten zur analyse - Google Patents
Stabilisierung von zellen und biologischen präparaten zur analyseInfo
- Publication number
- EP1425383A4 EP1425383A4 EP02768676A EP02768676A EP1425383A4 EP 1425383 A4 EP1425383 A4 EP 1425383A4 EP 02768676 A EP02768676 A EP 02768676A EP 02768676 A EP02768676 A EP 02768676A EP 1425383 A4 EP1425383 A4 EP 1425383A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- analysis
- damage
- cells
- vitro
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/549—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic with antigen or antibody entrapped within the carrier
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31415101P | 2001-08-23 | 2001-08-23 | |
US314151P | 2001-08-23 | ||
US36962802P | 2002-04-03 | 2002-04-03 | |
US369628P | 2002-04-03 | ||
PCT/US2002/026867 WO2003018757A2 (en) | 2001-08-23 | 2002-08-23 | Stabilization of cells and biological specimens for analysis |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1425383A2 EP1425383A2 (de) | 2004-06-09 |
EP1425383A4 true EP1425383A4 (de) | 2005-11-09 |
Family
ID=26979228
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02768676A Withdrawn EP1425383A4 (de) | 2001-08-23 | 2002-08-23 | Stabilisierung von zellen und biologischen präparaten zur analyse |
EP02761478A Expired - Lifetime EP1425294B2 (de) | 2001-08-23 | 2002-08-23 | Analyse zirkulierender tumorzellen, fragmente und trümmer |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02761478A Expired - Lifetime EP1425294B2 (de) | 2001-08-23 | 2002-08-23 | Analyse zirkulierender tumorzellen, fragmente und trümmer |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP1425383A4 (de) |
JP (3) | JP2005502863A (de) |
KR (2) | KR20040030984A (de) |
CN (2) | CN1571634A (de) |
AT (1) | ATE401574T1 (de) |
AU (2) | AU2008288601B2 (de) |
BR (2) | BR0212125A (de) |
CA (2) | CA2457894C (de) |
DE (1) | DE60227678D1 (de) |
IL (2) | IL160209A0 (de) |
WO (2) | WO2003018757A2 (de) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7863012B2 (en) | 2004-02-17 | 2011-01-04 | Veridex, Llc | Analysis of circulating tumor cells, fragments, and debris |
CN1571634A (zh) * | 2001-08-23 | 2005-01-26 | 免疫公司 | 用于分析的细胞和生物学标本的稳定 |
US8980568B2 (en) | 2001-10-11 | 2015-03-17 | Aviva Biosciences Corporation | Methods and compositions for detecting non-hematopoietic cells from a blood sample |
US8986944B2 (en) | 2001-10-11 | 2015-03-24 | Aviva Biosciences Corporation | Methods and compositions for separating rare cells from fluid samples |
CA2484876C (en) | 2002-05-13 | 2011-11-22 | Becton, Dickinson And Company | Protease inhibitor sample collection system |
EP2359689B1 (de) | 2002-09-27 | 2015-08-26 | The General Hospital Corporation | Mikrofluid-Vorrichtung zur Zelltrennung, sowie Verwendung derselben |
ES2784011T3 (es) | 2002-10-16 | 2020-09-21 | Streck Inc | Procedimiento y dispositivo para recoger y preservar las células para su análisis |
WO2004076643A2 (en) | 2003-02-27 | 2004-09-10 | Immunivest Corporation | CIRCULATING TUMOR CELLS (CTC’s): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS |
EP1673611A4 (de) * | 2003-09-18 | 2011-11-30 | Immunivest Corp | Operatorunabhängige programmierbare probenpräparations- und analysesystem |
DK1861509T3 (da) * | 2005-03-14 | 2015-12-07 | Janssen Diagnostics Llc | Fremgangsmåde til forudsigelse af progressionsfri og overordnet overlevelse for hvert opfølgningstidspunkt under behandling af patienter med metastatisk brystkræft under anvendelse af cirkulerende tumorceller |
US20070196820A1 (en) | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
EP2500439B2 (de) | 2005-06-20 | 2017-08-16 | Advanced Cell Diagnostics, Inc. | Verfahren zum Nachweis von Nukleinsäuren in einzelnen Zellen und zur Identifikation seltener Zellen aus großen heterogenen Zellpopulationen |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US8337755B2 (en) | 2006-03-13 | 2012-12-25 | Veridex, Llc | Operator independent programmable sample preparation and analysis system |
NZ573187A (en) * | 2006-06-02 | 2011-11-25 | Pfizer Prod Inc | Circulating tumor cell assay for predicting efficacy of 1gf-1r antagonist therapy |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
EP2589668A1 (de) | 2006-06-14 | 2013-05-08 | Verinata Health, Inc | Analyse seltener Zellen mittels Probentrennung und DNA-Etiketten |
EP2029779A4 (de) | 2006-06-14 | 2010-01-20 | Living Microsystems Inc | Verwendung hoch paralleler snp-genotypisierung zur fötalen diagnose |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
CN101583722A (zh) | 2006-07-14 | 2009-11-18 | 阿维瓦生物科学股份有限公司 | 从生物学样品检测稀有细胞的方法和组合物 |
JP5409395B2 (ja) * | 2007-02-27 | 2014-02-05 | セントクローネ インターナショナル エービー | 細胞外マーカーに結合する剤のパネルを用いる腫瘍細胞の多重検出 |
WO2008128243A1 (en) | 2007-04-16 | 2008-10-23 | Immunivest Corporation | A rapid, semi-automated method to detect respiratory virus infected cells in direct specimens |
US8003314B2 (en) | 2007-04-16 | 2011-08-23 | Diagnostic Hybrids, Inc. | Methods for direct fluorescent antibody virus detection in liquids |
US7828968B2 (en) | 2007-08-30 | 2010-11-09 | Veridex, Llc | Method and apparatus for imaging target components in a biological sample using permanent magnets |
US8110101B2 (en) | 2007-08-30 | 2012-02-07 | Veridex, Llc | Method and apparatus for imaging target components in a biological sample using permanent magnets |
EP2229441B1 (de) | 2007-12-12 | 2014-10-01 | The Board of Trustees of The Leland Stanford Junior University | Verfahren und vorrichtung zur magnetischen trennung von zellen |
US20100112575A1 (en) | 2008-09-20 | 2010-05-06 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive Diagnosis of Fetal Aneuploidy by Sequencing |
US11634747B2 (en) | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
DE202010018569U1 (de) | 2009-02-18 | 2017-09-26 | Streck Inc. | Konservierung zellfreier Nukleinsäuren |
WO2011038403A1 (en) | 2009-09-28 | 2011-03-31 | Yuling Luo | Methods of detecting nucleic acid sequences with high specificity |
CN115060882A (zh) * | 2009-10-21 | 2022-09-16 | 斯克里普斯研究所 | 用非稀有细胞检测稀有细胞的方法 |
US20130171621A1 (en) | 2010-01-29 | 2013-07-04 | Advanced Cell Diagnostics Inc. | Methods of in situ detection of nucleic acids |
WO2011099565A1 (ja) * | 2010-02-10 | 2011-08-18 | シスメックス株式会社 | 血液中癌細胞の検出方法及びそれに用いるプログラム |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
AU2011255641A1 (en) | 2010-05-18 | 2012-12-06 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
DE102010020785A1 (de) * | 2010-05-18 | 2011-11-24 | Siemens Aktiengesellschaft | Vorrichtung und Verfahren zum Erkennen von magnetisch markierten Mikroobjekten |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20120252038A1 (en) * | 2011-04-01 | 2012-10-04 | Chianese David A | Steroid receptor assays |
WO2012151391A2 (en) | 2011-05-04 | 2012-11-08 | Streck, Inc. | Inactivated virus compositions and methods of preparing such compositions |
US20140295426A1 (en) * | 2011-07-28 | 2014-10-02 | Veridex Llc | Methods for Diagnosing Cancer by Characterization of Tumor Cells Associated with Pleural or Serous Fluids |
WO2013045458A1 (en) | 2011-09-26 | 2013-04-04 | Preanalytix Gmbh | Stabilisation and isolation of extracellular nucleic acids |
US11021733B2 (en) | 2011-09-26 | 2021-06-01 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
KR102037891B1 (ko) * | 2012-03-09 | 2019-10-30 | 한국전자통신연구원 | 다중 분리 장치 및 혈중 암세포 분리 방법 |
US20150148212A1 (en) | 2012-05-10 | 2015-05-28 | Konica Minolta, Inc. | Process for removing red blood cells and centrifugal tube for blood collection |
CN104755628B (zh) | 2012-09-25 | 2019-03-01 | 凯杰有限公司 | 生物样品的稳定化 |
CN105264127B (zh) | 2013-03-15 | 2019-04-09 | Gpb科学有限责任公司 | 颗粒的片上微流体处理 |
US10324011B2 (en) | 2013-03-15 | 2019-06-18 | The Trustees Of Princeton University | Methods and devices for high throughput purification |
US20150064153A1 (en) | 2013-03-15 | 2015-03-05 | The Trustees Of Princeton University | High efficiency microfluidic purification of stem cells to improve transplants |
US11525155B2 (en) | 2013-03-18 | 2022-12-13 | Qiagen Gmbh | Stabilisation of biological samples |
EP2976426A1 (de) * | 2013-03-18 | 2016-01-27 | Qiagen GmbH | Stabilisierung und isolierung extrazellulärer nukleinsäuren |
ES2938048T3 (es) | 2013-07-24 | 2023-04-04 | Streck Llc | Composiciones y procedimientos para estabilizar las células tumorales circulantes |
CN105899679A (zh) * | 2013-10-21 | 2016-08-24 | 通用医疗公司 | 与循环肿瘤细胞簇有关的方法以及癌症的治疗 |
EA201691496A1 (ru) | 2014-01-27 | 2016-12-30 | Эпик Сайенсиз, Инк. | Диагностика биомаркеров рака предстательной железы с помощью циркулирующих опухолевых клеток |
WO2015127008A1 (en) | 2014-02-21 | 2015-08-27 | Epic Sciences, Inc. | Methods for analyzing rare circulating cells |
WO2015140218A1 (en) * | 2014-03-18 | 2015-09-24 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
CN103940997B (zh) * | 2014-03-21 | 2017-01-04 | 上海柏慧康生物科技有限公司 | 一种乳腺癌循环肿瘤细胞检测系统及试剂盒 |
CN106460070B (zh) | 2014-04-21 | 2021-10-08 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
CN103980365A (zh) * | 2014-06-03 | 2014-08-13 | 国家纳米科学中心 | 一种表面固载炭疽致死因子的磁性纳米粒子、其制备方法及用途 |
ES2872344T3 (es) * | 2014-07-02 | 2021-11-02 | Siemens Healthcare Diagnostics Inc | Separación selectiva de ácidos nucleicos |
US10564075B2 (en) | 2015-02-24 | 2020-02-18 | Siemens Healthcare Diagnostics Inc. | Prefixation for increased rare cell recovery |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
CA2936167A1 (en) * | 2015-07-15 | 2017-01-15 | Streck, Inc. | Method and device for stabilizing of proteins |
JP6617495B2 (ja) * | 2015-09-18 | 2019-12-11 | 東ソー株式会社 | 腫瘍細胞の検出方法 |
US20180328848A1 (en) * | 2015-11-04 | 2018-11-15 | Axon Dx, Llc | Cell detection, capture, analysis, aggregation, and output methods and apparatus |
US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
CN114457068A (zh) | 2015-11-20 | 2022-05-10 | 凯杰有限公司 | 用于稳定细胞外核酸的已灭菌组合物的制备方法 |
CN105372109A (zh) * | 2015-12-15 | 2016-03-02 | 苏州药明康德新药开发股份有限公司 | 添加稳定剂的生物基质的制备方法 |
US10945428B2 (en) | 2016-03-04 | 2021-03-16 | Menarini Silicon Biosystems S.P.A. | Preservation of cellular components from cells with a preservative |
JP7064665B2 (ja) * | 2016-03-07 | 2022-05-11 | ファーザー フラナガンズ ボーイズ ホーム ドゥーイング ビジネス アズ ボーイズ タウン ナショナル リサーチ ホスピタル | 非侵襲的分子対照 |
JP2017219479A (ja) | 2016-06-09 | 2017-12-14 | 住友電気工業株式会社 | 微小粒子計測装置及び分析方法 |
EP3491381A1 (de) | 2016-07-29 | 2019-06-05 | Streck, Inc. | Suspensionszusammensetzung zur kontrolle einer hämatologischen analyse |
US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
SG10202100951SA (en) | 2016-11-21 | 2021-03-30 | Nanostring Technologies Inc | Chemical compositions and methods of using same |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
WO2019025387A1 (de) * | 2017-08-02 | 2019-02-07 | Sarstedt Ag & Co. Kg | Verfahren und zusammensetzung zur stabilisierung zellfreier nukleinsäuren und zellen |
EP3675876A4 (de) | 2017-09-01 | 2021-06-02 | GPB Scientific, Inc. | Verfahren zur herstellung therapeutisch aktiver zellen unter verwendung von mikrofluidik |
EP3697209A4 (de) * | 2017-10-19 | 2021-07-28 | Streck, Inc. | Zusammensetzungen zur hämolyse- und gerinnungsregulierung sowie stabilisierung von extrazellulären vesikeln |
CA3099909A1 (en) | 2018-05-14 | 2019-11-21 | Nanostring Technologies, Inc. | Chemical compositions and methods of using same |
JP7334468B2 (ja) * | 2018-05-29 | 2023-08-29 | 東ソー株式会社 | 血液試料保存剤 |
JP7036670B2 (ja) | 2018-05-31 | 2022-03-15 | アークレイ株式会社 | 血液中の稀少細胞検査、該検査ための血液処理方法及び採血管 |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
CN108865976B (zh) * | 2018-07-19 | 2022-06-28 | 复旦大学附属中山医院 | 一种离散汲取收集外泌体(exosome)的方法及试剂 |
CN110250159A (zh) * | 2019-05-28 | 2019-09-20 | 天津中科生物科技有限公司 | 一种细胞保护液及其制备方法和应用 |
JP7355473B1 (ja) | 2022-03-25 | 2023-10-03 | 積水メディカル株式会社 | 循環腫瘍細胞分離キット、循環腫瘍細胞分離容器及び循環腫瘍細胞の分離方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2475737A1 (fr) * | 1980-02-07 | 1981-08-14 | Pasteur Institut | Perfectionnements apportes aux procedes de conservation d'hematies par lyophilisation en vue de leur utilisation dans des reactions d'hemagglutination et hematies non agglutinables spontanement obtenues par ce procede |
US4404181A (en) * | 1981-10-15 | 1983-09-13 | Cambridge Chemical Products, Inc. | Extended-life tissue fixative composition and method of using the same |
EP0161770A2 (de) * | 1984-05-14 | 1985-11-21 | Becton Dickinson and Company | Auflösungsmittel zur Bestimmung von peripherischen Blutzellen |
WO1993005650A1 (en) * | 1991-09-20 | 1993-04-01 | Camiener Gerald W | Methods and compositions with aldehyde stabilizing solution |
WO1994018828A1 (en) * | 1993-02-25 | 1994-09-01 | Abbott Laboratories | Multipurpose reagent system for rapid lysis of whole blood samples |
WO1997008557A1 (en) * | 1995-08-28 | 1997-03-06 | Miltenyi Biotech Gmbh | Efficient enrichment and detection of disseminated tumor cells |
WO1997045729A1 (en) * | 1996-05-24 | 1997-12-04 | Northern General Hospital Nhs Trust | Specimen collection fluid |
US5849517A (en) * | 1991-05-08 | 1998-12-15 | Streck Laboratories, Inc. | Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same |
US6197523B1 (en) * | 1997-11-24 | 2001-03-06 | Robert A. Levine | Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4040785A (en) * | 1976-10-18 | 1977-08-09 | Technicon Instruments Corporation | Lysable blood preservative composition |
US4320111A (en) * | 1977-06-14 | 1982-03-16 | American Home Products Corporation | Immunologic compositions methods of preparation and use |
FR2523810B1 (fr) * | 1982-03-23 | 1988-11-25 | Carpentier Alain | Tissu biologique greffable et procede pour sa preparation |
FR2528848A1 (fr) * | 1982-06-16 | 1983-12-23 | Sanofi Sa | Nouveau derive de thieno-pyridone, son procede de preparation et son application therapeutique |
EP0156537A3 (de) * | 1984-03-02 | 1987-05-13 | Board Of Regents University Of Texas System | Biologische magnetische Flüssigkeiten |
US4788139A (en) * | 1987-08-06 | 1988-11-29 | Streck Laboratories, Inc. | Platelet aggregation reagent, reagent container and method of determining platelet aggregation in EDTA-anticoagulated blood |
US5385707A (en) * | 1988-12-28 | 1995-01-31 | Stefan Miltenyi | Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same |
US5698271A (en) * | 1989-08-22 | 1997-12-16 | Immunivest Corporation | Methods for the manufacture of magnetically responsive particles |
US6670197B2 (en) * | 1997-11-24 | 2003-12-30 | David L. Rimm | Method for assaying whole blood for the presence or absence of circulating cancer or other target cell fragments |
EP1062515B1 (de) * | 1998-02-12 | 2009-11-25 | Immunivest Corporation | Verfahren und reagenzien zur raschen und effizienten isolierung zirkulierender krebszellen |
US6960449B2 (en) * | 1999-02-10 | 2005-11-01 | Cell Works Diagnostics, Inc. | Class characterization of circulating cancer cells isolated from body fluids and methods of use |
AU7351800A (en) * | 1999-09-13 | 2001-04-17 | Neil H. Bander | A method for isolation of prostatic epithelial cells from semen |
CN1571634A (zh) * | 2001-08-23 | 2005-01-26 | 免疫公司 | 用于分析的细胞和生物学标本的稳定 |
-
2002
- 2002-08-23 CN CNA02820820XA patent/CN1571634A/zh active Pending
- 2002-08-23 WO PCT/US2002/026867 patent/WO2003018757A2/en active Application Filing
- 2002-08-23 IL IL16020902A patent/IL160209A0/xx unknown
- 2002-08-23 EP EP02768676A patent/EP1425383A4/de not_active Withdrawn
- 2002-08-23 JP JP2003523961A patent/JP2005502863A/ja active Pending
- 2002-08-23 BR BR0212125-5A patent/BR0212125A/pt not_active IP Right Cessation
- 2002-08-23 KR KR10-2004-7002572A patent/KR20040030984A/ko not_active Application Discontinuation
- 2002-08-23 BR BR0212124-7A patent/BR0212124A/pt not_active Application Discontinuation
- 2002-08-23 IL IL16021002A patent/IL160210A0/xx unknown
- 2002-08-23 DE DE60227678T patent/DE60227678D1/de not_active Expired - Lifetime
- 2002-08-23 CN CNA028212002A patent/CN1596265A/zh active Pending
- 2002-08-23 WO PCT/US2002/026861 patent/WO2003019141A2/en active Application Filing
- 2002-08-23 KR KR10-2004-7002473A patent/KR20040053115A/ko not_active Application Discontinuation
- 2002-08-23 JP JP2003523608A patent/JP2005501236A/ja active Pending
- 2002-08-23 CA CA2457894A patent/CA2457894C/en not_active Expired - Fee Related
- 2002-08-23 CA CA2457891A patent/CA2457891C/en not_active Expired - Fee Related
- 2002-08-23 EP EP02761478A patent/EP1425294B2/de not_active Expired - Lifetime
- 2002-08-23 AT AT02761478T patent/ATE401574T1/de not_active IP Right Cessation
-
2008
- 2008-12-24 AU AU2008288601A patent/AU2008288601B2/en not_active Ceased
-
2009
- 2009-01-02 AU AU2009200013A patent/AU2009200013B2/en not_active Ceased
- 2009-01-21 JP JP2009011194A patent/JP2009109514A/ja active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2475737A1 (fr) * | 1980-02-07 | 1981-08-14 | Pasteur Institut | Perfectionnements apportes aux procedes de conservation d'hematies par lyophilisation en vue de leur utilisation dans des reactions d'hemagglutination et hematies non agglutinables spontanement obtenues par ce procede |
US4404181A (en) * | 1981-10-15 | 1983-09-13 | Cambridge Chemical Products, Inc. | Extended-life tissue fixative composition and method of using the same |
EP0161770A2 (de) * | 1984-05-14 | 1985-11-21 | Becton Dickinson and Company | Auflösungsmittel zur Bestimmung von peripherischen Blutzellen |
US5849517A (en) * | 1991-05-08 | 1998-12-15 | Streck Laboratories, Inc. | Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same |
WO1993005650A1 (en) * | 1991-09-20 | 1993-04-01 | Camiener Gerald W | Methods and compositions with aldehyde stabilizing solution |
WO1994018828A1 (en) * | 1993-02-25 | 1994-09-01 | Abbott Laboratories | Multipurpose reagent system for rapid lysis of whole blood samples |
WO1997008557A1 (en) * | 1995-08-28 | 1997-03-06 | Miltenyi Biotech Gmbh | Efficient enrichment and detection of disseminated tumor cells |
WO1997045729A1 (en) * | 1996-05-24 | 1997-12-04 | Northern General Hospital Nhs Trust | Specimen collection fluid |
US6197523B1 (en) * | 1997-11-24 | 2001-03-06 | Robert A. Levine | Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood |
Also Published As
Publication number | Publication date |
---|---|
EP1425294B1 (de) | 2008-07-16 |
AU2008288601A1 (en) | 2009-04-02 |
EP1425294A2 (de) | 2004-06-09 |
IL160210A0 (en) | 2004-07-25 |
AU2009200013A1 (en) | 2009-02-05 |
JP2005502863A (ja) | 2005-01-27 |
CA2457894C (en) | 2014-07-08 |
JP2005501236A (ja) | 2005-01-13 |
WO2003019141A3 (en) | 2004-04-01 |
ATE401574T1 (de) | 2008-08-15 |
CA2457894A1 (en) | 2003-03-06 |
AU2009200013B2 (en) | 2012-03-08 |
WO2003018757A3 (en) | 2003-09-12 |
CA2457891A1 (en) | 2003-03-06 |
IL160209A0 (en) | 2004-07-25 |
BR0212124A (pt) | 2004-07-20 |
WO2003019141A2 (en) | 2003-03-06 |
EP1425294A4 (de) | 2005-11-16 |
DE60227678D1 (de) | 2008-08-28 |
CN1571634A (zh) | 2005-01-26 |
KR20040030984A (ko) | 2004-04-09 |
JP2009109514A (ja) | 2009-05-21 |
KR20040053115A (ko) | 2004-06-23 |
BR0212125A (pt) | 2005-06-28 |
AU2008288601B2 (en) | 2012-05-31 |
EP1425294B2 (de) | 2012-12-12 |
EP1425383A2 (de) | 2004-06-09 |
CA2457891C (en) | 2019-10-01 |
WO2003018757A2 (en) | 2003-03-06 |
CN1596265A (zh) | 2005-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL160210A0 (en) | Stabilization of cells and biological specimens for analysis | |
Lazar et al. | Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line | |
EP2169387B1 (de) | Hochsensibles Multiparameterverfahren zur Analyse seltener Ereignisse in biologischen Proben | |
NZ333830A (en) | Method for assessing chemosensitivity of a biopsy sample | |
WO2008109414A3 (en) | Use of endogenous fluorescence to identify invading metastatic breast tumor cells | |
Kervarrec et al. | Merkel cell carcinomas infiltrated with CD33+ myeloid cells and CD8+ T cells are associated with improved outcome | |
WO2003106157A3 (en) | AUTOMATIC BLADE COLORING APPARATUS | |
Baker et al. | Rapid cervical cytology screening | |
Subramanian et al. | Significance of bone marrow fibrosis in multiple myeloma | |
Teman et al. | Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study | |
WO2003023354A3 (en) | Optical bio-disc systems for nuclear morphology based identification | |
Pijanka et al. | Spectroscopic signatures of single, isolated cancer cell nuclei using synchrotron infrared microscopy | |
Cattan et al. | Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis | |
Böttger et al. | DNA image cytometry. A prognostic tool in squamous cell carcinoma of the esophagus? | |
Simons et al. | Effects of histological staining on the analysis of human DNA from archived slides | |
Gong et al. | Clonal status and clinicopathological features of Langerhans cell histiocytosis | |
Woolman et al. | Rapid determination of the tumour stroma ratio in squamous cell carcinomas with desorption electrospray ionization mass spectrometry (DESI-MS): a proof-of-concept demonstration | |
Zver et al. | Minimal residual disease detection in cryopreserved ovarian tissue by multicolor flow cytometry in acute myeloid leukemia | |
WO2011033290A3 (en) | Dual fluorescence assay for determining viability of parasitic or non- parasitic worms | |
Toman | What are the advantages and disadvantages of fluorescence microscopy | |
Zver et al. | Validation of an automated technique for ovarian cortex dissociation: isolation of viable ovarian cells and their qualification by multicolor flow cytometry | |
Shen et al. | Accurate and noninvasive embryos screening during in vitro fertilization (IVF) assisted by Raman analysis ofembryos culture medium | |
Balasubramanian et al. | Isolation and characterization of circulating tumor cells (CTCs) from peripheral blood specimens of patients with advanced solid tumor malignancies (using ApoStream (TM) instrumentation) | |
Zickuhr et al. | Spatial Metabolomics co-registered with Multiplex Phenotyping for the Evaluation of Human Kidney Tissue | |
Dao et al. | Using micro-synchrotron radiation x-ray fluorescence (µ-SRXRF) for trace metal imaging in the development of MRI contrast agents for prostate cancer imaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040315 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 01N 1/02 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050927 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 01N 1/02 B Ipc: 7G 01N 33/574 B Ipc: 7G 01N 33/543 A |
|
17Q | First examination report despatched |
Effective date: 20060623 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080508 |